This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Alberta directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Glutathione ethyl ester supplementation during pancreatic islet isolation improves viability and transplant outcomes in a murine marginal islet mass model.
PloS one · 2013
Latest funding
- $1,082,476
Graft localized drug delivery to augment beta cell replacement therapies for diabetes
CIHR · 2023 · Nominated PI
- $1,000,000
A First-in-human Trial of Autologous Induced Pluripotent Stem Cells (iPSC)-Derived Islets: Developing a Personalized Diabetes Therapy
CIHR · 2021 · Principal investigator
- $1,000,000
A deep phenotyping network for understanding human islet variation in health and diabetes
CIHR · 2021 · Co-investigator
1 publications.
Glutathione ethyl ester supplementation during pancreatic islet isolation improves viability and transplant outcomes in a murine marginal islet mass model.
do Amaral AS, Pawlick RL, Rodrigues E, Costal F, Pepper A, Galvão FH, Correa-Giannella ML, Shapiro AM
Graft localized drug delivery to augment beta cell replacement therapies for diabetes
Principal investigators: Pepper, Andrew R
Keywords: Beta Cells; Biomaterials; Cell Thearpies; Diabetes; Immunosuppression; Insulin; Islets; Transplantation
A First-in-human Trial of Autologous Induced Pluripotent Stem Cells (iPSC)-Derived Islets: Developing a Personalized Diabetes Therapy
Principal investigators: Shapiro, James; Kieffer, Timothy J; Korbutt, Gregory S; MacDonald, Patrick E; Pepper, Andrew R
Keywords: Autoimmunity; Autologous Human Ipscs; Beta Cell Replacement Therapy; Cell Replacement Therapy; Clinical Trial; Diabetes Treatment; Induced Pluripotent Stem Cells; Islet Transplantation; Personalized Cell Therapy; Stem Cell Biology
A deep phenotyping network for understanding human islet variation in health and diabetes
Principal investigators: MacDonald, Patrick E; Bruin, Jennifer E; Johnson, James D; Xia, Jianguo
Keywords: Biobanking; Diabetes; Electrophysiology; Environmental Contaminants; Genetic Risk; Genomics; Islets Of Langerhans; Metabolomics; Proteomics; Resources
Canada Research Chair - Tier 2
Principal investigators: Pepper, Andrew R
Keywords: Crc
A deep phenotyping network for understanding human islet variation in health and diabetes
Principal investigators: MacDonald, Patrick E; Bruin, Jennifer E; Johnson, James D; Xia, Jianguo
Keywords: Biobanking; Diabetes; Environmental Toxicology; Genetics; Genomics; Insulin; Islets Of Langerhans; Metabolomics; Pancreas; Proteomics
A First-in-human Trial of Autologous Induced Pluripotent Stem Cell (iPSC)-Derived Islets: Developing a Personalized Diabetes Therapy
Principal investigators: Shapiro, James; Kieffer, Timothy J; Korbutt, Gregory S; MacDonald, Patrick E; Pepper, Andrew R
Keywords: Beta Cell Replacement Therapy; Induced Pluripotent Stem Cells; Treatment For Diabetes
Development of an Immunosuppression Free Cellular Transplantation Platform
Principal investigators: Pepper, Andrew
Keywords: Diabetes; Cellular Transplantation; Biomaterials; Immunosuppression; Gene Editing; Medical Devices; Stem Cells; Islets of Langerhans; Beta Cells
The Canadian National Transplant Research Program: Increasing Donation and Improving Transplantation Outcomes
Principal investigators: West, Lori J; Caulfield, Timothy A; Hébert, Marie-Josée; Humar, Atul; Knoll, Gregory; Levings, Megan K; Mital, Seema; Roy, Denis-Claude; Schultz, Kirk R; Shapiro, James
Keywords: Bone Marrow; Increasing Donation; Inflammation; Organ Repair; Pediatrics; Solid Organs/Cells; Stem Cells; Tolerance/Immunomodulation; Transplant Complications; Transplantation
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.